GATC Acquires SOLiD™ DNA Sequencer from Applied Biosystems
News Aug 03, 2007
The system will be the third next generation sequencing technology to be installed in GATC's German research facility in Constance, which currently holds the GS FLX™ from Roche Diagnostics as well as the Genome Analyzer™ from Illumina.
According to GATC, being a part of Applied Biosystems' Early-Access Program, the SOLiD™ System is expected to be installed in early autumn this year and will boost the company's current sequencing capacity from 130 gigabases to 250 gigabases a year.
Therefore GATC will be the first and only commercial sequencing service provider worldwide being able to offer ultra high-throughput DNA analysis using all three leading next generation sequencing technologies, the company says. The total investment exceeds 2 million Euros.
When a protein named "Merlin" fails to do its job, people can develop slow-growing, life-disrupting auditory nerve tumors that can disrupt their hearing and balance. Now scientists at Cincinnati Children's have discovered much more about how Merlin does its job – by working behind the scenes through a network of more than 50 other proteins.READ MORE